A pioneer approach to preventing central venous catheter infections.
Richard W
RW
Carlson
Tetyana
T
Patterson
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000379:methods*; D000963:Antimetabolites / Q000627:therapeutic use*; D055499:Catheter-Related Infections / Q000517:prevention & control*; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000379:methods*; D002710:Chlorhexidine / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D012837:Silver Sulfadiazine / Q000627:therapeutic use*
D000891:Anti-Infective Agents, Local; D000963:Antimetabolites; D002710:Chlorhexidine; D005472:Fluorouracil; D012837:Silver Sulfadiazine